NAD+ declines with age, and precursors like NMN and NR may help restore it. Here's what current research actually supports.
Deep inside your cells, there's a critical molecule that makes energy production possible, repairs damaged DNA, and helps regulate some of the fundamental processes of aging. It's called NAD+, short for nicotinamide adenine dinucleotide, and it's present in every cell of your body. Yet most people have never heard of it. What's more striking is that by the time you reach middle age, you have significantly less of it than you did in your youth, and this decline appears to be directly connected to the aging process itself. Understanding NAD+, why it declines with age, and whether we can do anything to restore it has become one of the most actively researched areas in longevity science over the past two decades.
NAD+ functions as a crucial coenzyme, meaning it facilitates the work of other proteins and enzymes throughout your body. Think of NAD+ as a helper molecule that other proteins need to get their jobs done. Without adequate NAD+, these critical cellular processes simply cannot function efficiently. NAD+ is essential for extracting energy from the food you eat—it's directly involved in glycolysis and the citric acid cycle, the fundamental pathways that convert carbohydrates, fats, and proteins into ATP, the cellular currency of energy. Beyond energy production, NAD+ serves equally important roles in DNA repair. When your DNA is damaged by radiation, oxidative stress, or just the normal wear and tear of living, enzymes called PARP (poly-ADP-ribose polymerase) enzymes use NAD+ to repair these breaks. Additionally, NAD+ serves as a substrate for sirtuins, a class of enzymes that have earned the nickname "longevity proteins" because of their apparent role in regulating aging and promoting cellular health. NAD+ is also required for proper mitochondrial function—those powerhouse organelles that generate energy for your cells. Without adequate NAD+, your mitochondria cannot operate efficiently, leading to reduced energy production and the accumulation of harmful reactive oxygen species.
The real problem is that NAD+ levels don't stay constant across your lifespan. Starting in your 20s and accelerating through middle age and beyond, NAD+ concentrations decline substantially. Research suggests that by the time you reach your 60s, you have roughly 50% less NAD+ than you had in your 20s. Some studies suggest the decline is even steeper. This age-related decline in NAD+ appears to be a common feature across many organisms, from yeast to fruit flies to mice, and the pattern seems to hold true in humans as well. The consequences of this decline are potentially significant. As NAD+ levels drop, DNA repair becomes less efficient. Sirtuin activation diminishes. Mitochondrial function deteriorates. This may help explain why so many age-related diseases seem to emerge simultaneously in middle age—cardiovascular disease, metabolic dysfunction, cognitive decline, and increased cancer risk. Researchers have observed a striking correlation between NAD+ levels and the development of these age-related conditions, leading many scientists to hypothesize that restoring NAD+ levels might be an effective way to address multiple aspects of aging simultaneously.
This question—can we restore NAD+ levels and thereby slow or reverse aging—has motivated intense research over the past 15 years. The approach taken by scientists is elegant but indirect. NAD+ itself is a large, charged molecule that cannot easily cross cell membranes when taken orally as a supplement. Your digestive system would break it down, and even if some survived, the cells lining your gut would struggle to absorb it. The solution is to use precursors, smaller molecules that your cells can more readily absorb and that can then be converted back into NAD+ through different metabolic pathways. The two primary precursors being studied and commercially available are nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR).
NMN is a molecule that sits just one step away from NAD+ in the biosynthetic pathway. When you consume NMN, your cells can absorb it and convert it directly into NAD+ using an enzyme called NMNAT. NMN has become the most popular NAD+ precursor, in large part due to the advocacy and research of David Sinclair, a geneticist at Harvard Medical School who has spent decades studying the mechanisms of aging. Sinclair's laboratory has published numerous papers showing that NMN restores NAD+ levels and produces anti-aging effects in animal models. Sinclair himself takes NMN as a supplement and has prominently featured it in his public communications about longevity. The popularity of NMN has skyrocketed following the publication of Sinclair's books and his appearances on popular podcasts, where he discusses his personal use of the supplement.
NR takes a slightly different path. It's converted first into nicotinamide mononucleotide and then into NAD+ through a series of enzymatic reactions. NR has actually been studied in humans for longer than NMN, and it received FDA GRAS (Generally Recognized As Safe) status, which gives it a regulatory advantage. NR is sold commercially under the brand name Niagen or Tru Niagen and has become available in supplement stores and online for many years. Both compounds have generated significant interest from the longevity and anti-aging supplement communities, but they're fundamentally different in one important way: the quality and breadth of evidence supporting them differs substantially.
The research establishing that both NMN and NR can raise NAD+ levels in humans is solid. Multiple human studies have demonstrated that oral supplementation with either compound reliably increases blood NAD+ levels. The doses typically used in these studies range from 250 to 1000 milligrams daily, with NR studies often using 500 to 1000 milligrams and NMN studies using 250 to 750 milligrams. Some research suggests that sublingual delivery of NMN may improve absorption, though this remains somewhat controversial. Both compounds appear to be well-tolerated in the doses studied, with few side effects reported even in longer-term studies. This basic safety profile is reassuring and has allowed researchers to move forward with longer-term investigations.
However, there's a critical distinction between raising NAD+ levels and improving health outcomes. The animal research is genuinely impressive. In mice and other laboratory organisms, both NMN and NR supplementation has been associated with improvements in metabolic markers, better mitochondrial function, improved exercise capacity, enhanced glucose metabolism, and in some studies, modest lifespan extension. These animal studies have provided the mechanistic foundation and theoretical rationale for why NAD+ restoration might work in humans. The problem is that the human data—the data that actually matters for deciding whether you should take these supplements—is much thinner. Yes, we can show that oral NMN and NR raise blood NAD+ levels in humans. But do they actually improve human healthspan or lifespan? Do they reduce disease risk? Do they improve markers of biological age? These are the questions that matter, and the honest answer is that we simply don't have strong evidence yet.
The handful of human studies completed to date have been relatively small and short-term. They've demonstrated that the supplements are safe and that they increase NAD+ levels, but most have not shown dramatic improvements in meaningful health outcomes. Some studies have shown modest improvements in metabolic parameters or muscle function, but the effect sizes have been small. The longest-term human studies to date have followed participants for a few months, maybe a year at most. We have no randomized controlled trial data showing that NMN or NR improves longevity, reduces cardiovascular disease risk, decreases cancer incidence, or improves cognitive function in humans. This is the central gap in the evidence, and it's one that David Sinclair himself acknowledges. While Sinclair is bullish about NAD+ as a longevity intervention, he's been careful in interviews and presentations to distinguish between the compelling animal research and the still-limited human evidence.
This evidence gap has important implications for how we should think about NAD+ precursors. It means we're in a situation that requires intellectual honesty. The mechanism makes sense. The animal research is encouraging. The compounds appear safe. But we don't yet have proof that they work in humans for the purposes of life extension or disease prevention. This is why some longevity experts take a very different stance than Sinclair. Peter Attia, one of the most influential voices in preventive medicine and longevity, has stated publicly that he does not currently supplement with NAD+ precursors, despite acknowledging the interesting mechanistic rationale and animal research. Attia's position is that the evidence gap is simply too large at this stage. He prefers to focus resources and effort on interventions with stronger human evidence, such as exercise, sleep optimization, and metabolic health.
This distinction between Sinclair and Attia illustrates an important principle in longevity science: there's a meaningful difference between "plausible" and "proven." An intervention can be mechanistically sound, supported by excellent animal research, and still lack evidence of benefit in humans. The history of medicine is littered with compounds that worked beautifully in animal models but failed in human trials. This doesn't mean NAD+ precursors won't eventually prove beneficial in humans—larger and longer-term studies may well demonstrate real health benefits. But it does mean that at present, taking NMN or NR is a bet on the future rather than a claim supported by current evidence.
If you're interested in using NAD+ precursors experimentally, understanding the dosing and formulations available is important. NMN is typically available in doses of 250 to 500 milligrams per capsule, and studies suggest effective doses are in the range of 250 to 1000 milligrams daily. Some companies promote sublingual (under-the-tongue) delivery, claiming that this improves absorption by bypassing some digestive degradation. The theoretical basis for this is sound, though the practical benefit remains unclear. NR is similarly available in various formulations, with typical doses ranging from 300 to 1000 milligrams daily. Given that NR has been studied for longer and has FDA GRAS status, it may be considered slightly safer from a regulatory perspective, though both compounds have good safety profiles based on available data.
One of the frustrating aspects of the current landscape is that long-term safety data is genuinely limited for both compounds. Most human studies have followed participants for weeks to a few months. A few have extended to a year. But no compound should be considered fully safe without adequate long-term study, and when you're talking about supplements aimed at life extension, "long-term" ideally means years, if not decades. This doesn't mean the compounds are dangerous—there's no evidence of serious toxicity. But it does mean that anyone taking NMN or NR is, in a sense, participating in an ongoing experiment.
Rather than relying on supplements to maintain NAD+ levels, there are evidence-based approaches that can increase NAD+ naturally. Exercise is perhaps the most powerful. Regular endurance exercise, particularly sustained aerobic activity like running, cycling, or rowing, significantly increases NAD+ levels. Resistance training similarly boosts NAD+ by activating AMPK and mitochondrial biogenesis pathways. This is one reason why exercise is such a powerful intervention for longevity—it doesn't just improve fitness; it triggers beneficial cellular signaling pathways mediated by NAD+-dependent enzymes like sirtuins and PARP. Fasting and caloric restriction similarly increase NAD+ levels. When your cells sense energy depletion, they activate AMPK (the metabolic master switch), which in turn increases NAD+ levels as part of a coordinated response to enhance cellular survival. Even moderate intermittent fasting or time-restricted eating can boost NAD+ to some degree. Beyond these active approaches, simply avoiding NAD+ depletion is important. Chronic inflammation, excessive caloric intake, and metabolic dysfunction all reduce NAD+ levels and accelerate the aging clock. By maintaining a healthy diet, managing stress, optimizing sleep, and staying physically active, you're supporting NAD+ levels through multiple mechanisms.
The practical takeaway from the current state of NAD+ research is straightforward but perhaps unsatisfying for those hoping for a simple supplement solution. NAD+ is indeed a critical molecule for cellular health and longevity, and its age-related decline almost certainly contributes to aging. The precursor compounds NMN and NR can reliably increase blood NAD+ levels and appear to be safe. The animal research is genuinely compelling. However, the human evidence that these supplements improve healthspan, lifespan, or reduce disease risk remains insufficient. Until larger, longer-term human studies provide more convincing evidence, NAD+ precursors are best thought of as experimental interventions with potential but unproven benefit. If you choose to use them, they should be considered as additions to, never as replacements for, the proven longevity interventions: consistent exercise, quality sleep, stress management, a healthy diet, and strong social connections. The promise of NAD+ restoration through NMN/NR precursors is real, but the evidence is still being written.